{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.464.1003.1150",
  "meta" : {
    "versionId" : "7",
    "lastUpdated" : "2021-11-02T01:01:56.000-04:00",
    "profile" : ["http://hl7.org/fhir/StructureDefinition/shareablevalueset",
    "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueString" : "NCQA PHEMUR Author"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate" : "2022-12-15"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate" : "2021-11-02"
  }],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1150",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.464.1003.1150"
  }],
  "version" : "20211102",
  "name" : "SubstanceUseDisorderShortActingMedication",
  "title" : "Substance Use Disorder Short Acting Medication",
  "status" : "active",
  "experimental" : false,
  "date" : "2021-11-02T01:01:56-04:00",
  "publisher" : "NCQA PHEMUR",
  "jurisdiction" : [{
    "extension" : [{
      "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
      "valueString" : "UNKNOWN"
    }]
  }],
  "purpose" : "(Clinical Focus: The purpose of this Grouping value set is to represent concepts for short acting substance use disorder medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable naltrexone, buprenorphine and buprenorphine (oral, sublingual) medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes long acting implant and injection medications.)",
  "compose" : {
    "include" : [{
      "valueSet" : ["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1153"]
    },
    {
      "valueSet" : ["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1145"]
    },
    {
      "valueSet" : ["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1146"]
    },
    {
      "valueSet" : ["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1148"]
    },
    {
      "valueSet" : ["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1154"]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:cd9eec1d-8c79-4f0f-b529-0775cd9be125",
    "timestamp" : "2023-09-26T13:23:17-04:00",
    "total" : 21,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1010600",
      "display" : "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1010604",
      "display" : "buprenorphine 8 MG / naloxone 2 MG Sublingual Film"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1307056",
      "display" : "buprenorphine 4 MG / naloxone 1 MG Sublingual Film"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1307061",
      "display" : "buprenorphine 12 MG / naloxone 3 MG Sublingual Film"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1431076",
      "display" : "buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1431102",
      "display" : "buprenorphine 5.7 MG / naloxone 1.4 MG Sublingual Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1483744",
      "display" : "naltrexone hydrochloride 50 MG Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1542390",
      "display" : "buprenorphine 2.1 MG / naloxone 0.3 MG Buccal Film"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1544851",
      "display" : "buprenorphine 4.2 MG / naloxone 0.7 MG Buccal Film"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1544854",
      "display" : "buprenorphine 6.3 MG / naloxone 1 MG Buccal Film"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1597568",
      "display" : "buprenorphine 11.4 MG / naloxone 2.9 MG Sublingual Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1597573",
      "display" : "buprenorphine 8.6 MG / naloxone 2.1 MG Sublingual Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1666338",
      "display" : "buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1864412",
      "display" : "buprenorphine 0.7 MG / naloxone 0.18 MG Sublingual Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "197623",
      "display" : "disulfiram 250 MG Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "197624",
      "display" : "disulfiram 500 MG Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "351264",
      "display" : "buprenorphine 2 MG Sublingual Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "351265",
      "display" : "buprenorphine 8 MG Sublingual Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "351266",
      "display" : "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "351267",
      "display" : "buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "835726",
      "display" : "acamprosate calcium 333 MG Delayed Release Oral Tablet"
    }]
  }
}